en
Scientific article
English

Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment

Published inTransplantation, vol. 98, no. 9, p. 1013-1018
Publication date2014
Abstract

Cytomegalovirus (CMV) replication has been associated with more risk for solid organ graft rejection. We wondered whether this association still holds when patients at risk receive prophylactic treatment for CMV.

Citation (ISO format)
STERN, Martin et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. In: Transplantation, 2014, vol. 98, n° 9, p. 1013–1018. doi: 10.1097/TP.0000000000000160
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0041-1337
593views
0downloads

Technical informations

Creation11/11/2014 3:16:00 PM
First validation11/11/2014 3:16:00 PM
Update time03/14/2023 10:14:22 PM
Status update03/14/2023 10:14:22 PM
Last indexation01/16/2024 2:22:26 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack